Emergency Department Crowding in Relation to In-hospital Adverse Medical Events
NCT01116323 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 104000
Last updated 2021-08-06
Summary
Since the report "To Err is Human" by the Institute of Medicine (IOM) in 1999, attention was brought to the general public that adverse events in medicine are common and are one of the leading causes of morbidity and mortality within the United States. The report estimates that 44,000 - 98,000 patients hospitalized in the United States die each year as a result of medical errors.
In spite of the growing patient safety movement worldwide, health care has not become measurably safer. Health care is one of the few risk-prone areas in which public demand limits the use of common-sense safety-enhancing solutions, such as limiting the flow and choosing the type of incoming patients. The latter is especially true for emergency departments (EDs) since they deliver an important public service by providing emergency care 24 hours a day, 365 days per year, without discrimination by social or economic status. One of the key expectations of EDs is the ability to provide immediate access and stabilization for those patients who have an emergency medical condition. However, emergency department (ED) crowding is recognized to be a major, international problem that affects patients and providers. A recent report from the IOM noted that the increasing strain caused by crowding is creating a deficit in quality of emergency care. Crowding has been associated with reduced access to emergency medical services, delays in care for cardiac patients, increased patient mortality, inadequate pain management, increased costs of patient care, and delays in administration of antibiotic therapy.
Several issues remain concerning ED crowding and it's relation to adverse events. First, the existing evidence on adverse event occurrence during ED crowding is largely anecdotal and inconclusive. Secondly, although a few studies showed a relationship between ED crowding and mortality, neither of these examined the causes of excess mortality. Finally, although a significant increase in the average length of hospital stay was shown during ED crowding the reasons for this are open to speculation.
The purpose of this study therefore is to identify six explicit adverse events and mortality for patients who were admitted through ED and to compare these results in relation to ED crowding. This will provide us novel insight into the reasons for the hypothesized increased mortality during ED crowding.
Conditions
- Adverse Effects
Sponsors & Collaborators
-
KU Leuven
lead OTHER
Principal Investigators
-
Greet Van den Berghe, MD, Ph D · Catholic University Leuven
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-06-30
- Primary Completion
- 2012-09-30
- Completion
- 2013-12-31
Countries
- Belgium
Study Locations
More Related Trials
-
The NeXT Study; The Netherlands XTC Toxicity Study
NCT00235768 ·Status: COMPLETED
-
Medication Incidents in Primary Care Medicine
NCT02295371 ·Status: COMPLETED
-
Drug Interactions With Risk of QT-prolongation in a General Hospital
NCT02043912 ·Status: COMPLETED
-
Time Within the Acute Care Chain: How Long Have Medical Emergency Department Patients Spent
NCT06079099 ·Status: COMPLETED
-
Quantitative Xylazine Measurement in ED
NCT06949605 ·Status: COMPLETED
-
Identification of Psychoactive Substance Users in Young Adults (16 to 25 Years Old) Visiting the Emergency Department
NCT04173546 ·Status: COMPLETED
-
Evaluating Ketamine and Psychological Sequelae
NCT04053400 ·Status: COMPLETED
-
Low Dose Ketamine Intra Nasal Traumatology
NCT03233035 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacological Interaction Between Carvedilol and Methylenedioxymethamphetamine (MDMA)
NCT01270672 ·Status: COMPLETED ·Phase: NA
-
Functional Brain Imaging in Recreational Users of Ecstasy
NCT00254306 ·Status: COMPLETED
-
Prosocial Effects of MDMA
NCT05948683 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
The Human Stress Response in a Simulated ED Setting
NCT04317482 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Effects of MDMA-like Substances in Healthy Subjects
NCT04847206 ·Status: COMPLETED ·Phase: PHASE1
-
Medication Reconciliation in an Emergency Department: How to Prioritize Patients ?
NCT03955965 ·Status: COMPLETED
-
Ketamine for Low Mood States in the ER
NCT01209845 ·Status: COMPLETED ·Phase: PHASE1
-
Investigation of Serotonin Neurotransmission in MDMA Users Using Combinated Dexfenfluramine Challenge and PET Imaging
NCT01296802 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of Amantadine Hydrochloride for Treatment of Severe Traumatic Brain Injury (TBI)
NCT00970944 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effects of MDMA Co-administration on the Response to LSD in Healthy Subjects
NCT04516902 ·Status: COMPLETED ·Phase: PHASE1
-
Medical Students and Psychoactive Substances Use
NCT04209101 ·Status: COMPLETED
-
The Incidence, Clinical Characteristics and Outcome of Infective Endocarditis Among Intravenous Drug Abusers Versus Non-Drug Abusers.
NCT06194409 ·Status: RECRUITING
-
Oxytocin Administration and Emotion Recognition Abilities in Adults Reporting Adverse Childhood Experiences
NCT03335085 ·Status: COMPLETED ·Phase: NA
-
Acute Effects of 3,4-methylenedioxymethamphetamine (MDMA) With and Without a Booster Dose
NCT05809271 ·Status: COMPLETED ·Phase: PHASE1
-
Pain and Anxiety Management of Traumatic Emergency in a Pre-hospital Setting
NCT01151696 ·Status: COMPLETED ·Phase: PHASE4
-
ESM Pilot: Mobile Phones and Psychology
NCT03221985 ·Status: COMPLETED ·Phase: NA
-
Oxytocin, Trauma Disclosure and Intrusions
NCT03425929 ·Status: COMPLETED ·Phase: PHASE1